Abstract: Exposure to molds can cause human disease through several well-defined mechanisms. In addition, many new mold-related illnesses have been hypothesized in recent years that remain largely or completely unproved. Concerns about mold exposure and its effects are so common that all health care providers, particularly allergists and immunologists, are frequently faced with issues regarding these real and asserted mold-related illnesses. The purpose of this position paper is to provide a state-of-the-art review of the role that molds are known to play in human disease, including asthma, allergic rhinitis, allergic bronchopulmonary aspergillosis, sinusitis, and hypersensitivity pneumonitis. In addition, other purported mold-related illnesses and the data that currently exist to support them are carefully reviewed, as are the currently available approaches for the evaluation of both patients and the environment. Exposure to molds can cause human disease through several well-defined mechanisms. In addition, many new mold-related illnesses have been hypothesized in recent years that remain largely or completely unproved. Concerns about mold exposure and its effects are so common that all health care providers, particularly allergists and immunologists, are frequently faced with issues regarding these real and asserted mold-related illnesses. The purpose of this position paper is to provide a state-of-the-art review of the role that molds are known to play in human disease, including asthma, allergic rhinitis, allergic bronchopulmonary aspergillosis, sinusitis, and hypersensitivity pneumonitis. In addition, other purported mold-related illnesses and the data that currently exist to support them are carefully reviewed, as are the currently available approaches for the evaluation of both patients and the environment. Exposure to certain fungi (molds) can cause human illness. Molds cause adverse human health effects through 3 specific mechanisms: generation of a harmful immune response (eg, allergy or hypersensitivity pneumonitis [HP]), direct infection by the organism, and toxic-irritant effects from mold byproducts. For each of these defined pathophysiologic mechanisms, there are scientifically documented mold-related human diseases that present with objective clinical evidence of disease. Recently, in contrast to these well-accepted mold-related diseases, a number of new mold-related illnesses have been hypothesized. This has become a particular issue in litigation that has arisen out of unproved assertions that exposure to indoor molds causes a variety of ill-defined illnesses. Many of these illnesses are characterized by the absence of objective evidence of disease and the lack of a defined pathology and are typically without specificity for the involved fungus–fungal product purported to cause the illness. In this position paper we will review the state of the science of mold-related diseases and provide interpretation as to what is and what is not supported by scientific evidence. This is important for members of the allergy–clinical immunology community, who are frequently asked by patients, parents, and other interested parties to render opinions about the relationship of mold exposure to a variety of patient complaints. Given the nature of this document, key rather than exhaustive citations are provided. The latter can be found in documents such as the Institute of Medicine reports “Damp indoor spaces and health”1Committee on Damp Indoor Spaces and Health Board of Health Promotion and Disease Prevention. Institute of Medicine of the National Academies. Damp indoor spaces and health. The National Academies Press, Washington (DC)2004Google Scholar and “Clearing the air: asthma and indoor air exposure.”2Committee on the Assessment of Asthma and Indoor Air Division of Health Promotion and Disease Prevention. Institute of Medicine. Clearing the air: asthma and indoor air exposure. The National Academy Press, Washington (DC)2002Google Scholar It is estimated that approximately 10% of the population have IgE antibodies to common inhalant molds.3Horner W.E. Helbing A. Salvaggio J.E. Lehrer S.B. Fungal allergens.Clin Microbiol Rev. 1995; 8: 161-179Crossref PubMed Google Scholar About half of these individuals (5% of the population) are predicted to have, at some time, allergic symptoms as a consequence of exposure to fungal allergens.4ACOEM Council on Scientific Affairs American College of Environmental and Occupational Medicine position statement. Adverse health effects associated with molds in the indoor environment. ACOEM, Elk Grove Village (Ill)2002Google Scholar Although indoor fungal allergen exposure occurs, outdoor exposure is generally more relevant in terms of sensitization and disease expression. The role of indoor fungi in the pathogenesis of allergic disease has been extensively reviewed in recent reports from the Institute of Medicine of the National Academy of Science.1Committee on Damp Indoor Spaces and Health Board of Health Promotion and Disease Prevention. Institute of Medicine of the National Academies. Damp indoor spaces and health. The National Academies Press, Washington (DC)2004Google Scholar Sensitization to fungi, particularly Alternaria alternata, has been linked to the presence, persistence, and severity of asthma.5Bush R.K. Prochnau J.J. Alternaria-induced asthma.J Allergy Clin Immunol. 2004; 113: 227-234Abstract Full Text Full Text PDF PubMed Scopus (267) Google Scholar Exposure to atmospheric fungal spores (principally in the outdoor environment) has been related to asthma symptoms and medication use in children with asthma.6Delfino R.J. Caote B.D. Zeiger R.S. Seltzer J.M. Street D.H. Koutrakis P. Daily asthma severity in relation to personal ozone exposure and outdoor fungal spores.Am J Respir Crit Care Med. 1996; 154: 633-641Crossref PubMed Scopus (171) Google Scholar The association of asthma symptoms and exposure to indoor fungi is less clearly established. Literature reviews suggest that children living in damp houses, homes with visible mold growth, or both were more likely to experience lower respiratory tract symptoms of cough and wheeze than children who do not.7Verhoeff A.P. Burge H.A. Health risk assessment of fungi in home environments.Ann Allergy Asthma Immunol. 1997; 78: 544-554Abstract Full Text PDF PubMed Scopus (220) Google Scholar, 8Peat J. Dickerson J. Li J. Effects of damp and mould in the home on respiratory health: a review of the literature.Allergy. 1998; 53: 120-128Crossref PubMed Scopus (277) Google Scholar Recent prospective epidemiologic studies have shown that infants at risk for asthma, defined by a maternal history of asthma, who are exposed to high concentrations of indoor fungi (in addition to cockroach allergen and nitrogen dioxide sources) in the first year of life are at risk for persistent wheezing and cough.9Gent J.F. Ren P. Bealanger K. Triche E. Bracken M.B. Holford T.R. et al.Levels of household mold associated with respiratory symptoms in the first year of life in a cohort at risk for asthma.Environ Health Perspect. 2002; 110: A781-A786Crossref PubMed Scopus (144) Google Scholar, 10Belanger K. Beckett Wm Triche E. Bracken M.B. Holford T. Ren P. et al.Symptoms of wheeze and persistent cough in the first year of life: association with indoor allergens air contaminants, and maternal history of asthma.Am J Epidemiol. 2003; 158: 195-202Crossref PubMed Scopus (186) Google Scholar These and similar epidemiologic reports fall short of prospective studies that control for confounding factors, such as humidity and other airborne allergens and irritants. Molds are often presumed to be an important cause of the other atopic manifestations, including allergic rhinitis and, to a far lesser degree, atopic dermatitis. Abundant published data have established that sensitization (by skin testing, circulating IgE antibodies, or both) to one or more airborne molds occurs in these diseases, although sensitization is less frequent to molds than to pollens, animal danders, and house dust mite. Current studies do not conclusively demonstrate a causal relationship of airborne mold exposure and clinical manifestations of allergic rhinitis. The data on outdoor molds (eg, Alternaria species and basidiomycetes) purportedly causing allergic rhinitis are indirect and conflicting.11Andersson M. Downs S. Mitakakis T. Leuppi J. Marks G. Natural exposure to Alternaria spores induces allergic rhinitis symptoms in sensitized children.Pediatr Allergy Immunol. 2003; 14: 100-105Crossref PubMed Scopus (60) Google Scholar, 12Helbling A. Gayer F. Pichler W.J. Brander K.A. Mushroom (basidiomycete) allergy: diagnosis established by skin test and nasal challenge.J Allergy Clin Immunol. 1998; 83: 853-858Abstract Full Text Full Text PDF Scopus (38) Google Scholar, 13Gergen P.J. Turkeltaub P.C. The association of individual allergen reactivity with respiratory disease in a national sample: data from the second National Health and Nutrition Examination Survey, 1976-80 (NHANES II).J Allergy Clin Immunol. 1992; 90: 579-588Abstract Full Text PDF PubMed Scopus (214) Google Scholar Studies attempting to correlate indoor molds with symptomatic allergic rhinitis are even more problematic because of such methodological uncertainties as lack of quantitative mold sampling14Rowe M.S. Bailey J. Ownby D.R. Evaluation of the cause of nasal and ocular symptoms associated with lawn mowing.J Allergy Clin Immunol. 1986; 77: 714-719Abstract Full Text PDF PubMed Scopus (21) Google Scholar, 15Lander F. Meyer H.W. Norn S. Serum IgE specific to indoor moulds, measured by basophil histamine release, is associated with building-related symptoms in damp buildings.Inflamm Res. 2001; 50: 227-231Crossref PubMed Scopus (35) Google Scholar, 16Katz Y. Verleger H. Barr J. Rachmiel M. Kiviti S. Kuttin E.S. Indoor survey of moulds and prevalence of mould atopy in Israel.Clin Exp Allergy. 1999; 2: 186-192Crossref Scopus (78) Google Scholar and inclusion of upper respiratory tract infections.17Huang S.W. Kimbrough J.W. Mold allergy is a risk factor for persistent cold-like symptoms in children.Clin Pediatr (Phila). 1997; 36: 695-699Crossref PubMed Scopus (13) Google Scholar Published reports document mold sensitivity in some children and adults with atopic dermatitis.18Montealegre F. Meyer B. Chardon D. Vargas W. Zavala D. Hart B. et al.Comparative prevalence of sensitization to common animal, plant and mould allergens in subjects with asthma, or atopic dermatitis and/or allergic rhinitis living in a tropical environment.Clin Exp Allergy. 2004; 34: 51-58Crossref PubMed Scopus (46) Google Scholar, 19Reijula K. Leino M. Mussalo-Rauhamaa H. Nikulin M. Alenius H. Mikkola J. et al.IgE-mediated allergy to fungal allergens in Finland with special reference to Alternaria alternata and Cladosporium herbarium.Ann Allergy Asthma Immunol. 2003; 91: 280-287Abstract Full Text PDF PubMed Scopus (60) Google Scholar, 20Scalabrin D.M. Bavbek S. Perzanowski M.S. Wilson B.B. Platts-Mills T.A. Wheatley L.M. Use of specific IgE in assessing the relevance of fungal and dust mite allergens to atopic dermatitis: a comparison with asthmatic and non-asthmatic control subjects.J Allergy Clin Immunol. 1999; 104: 1273-1279Abstract Full Text Full Text PDF PubMed Scopus (151) Google Scholar However, there are no publications that establish a causal role for airborne molds in this disease rather than the IgE antibodies simply reflecting an expected concomitant of their atopic state. There are no credible reports in the medical literature documenting indoor exposure to molds as a cause of the nonatopic IgE-mediated diseases (eg, urticaria-angioedema and anaphylaxis). Conclusions:•Atopic patients (those with allergic asthma, allergic rhinitis, and atopic dermatitis) commonly have IgE antibodies to molds as part of polysensitization.•Allergic responses to inhaled mold antigens are a recognized factor in lower airway disease (ie, asthma).•Currently available studies do not conclusively prove that exposure to outdoor airborne molds plays a role in allergic rhinitis, and studies on the contribution of indoor molds to upper airway allergy are even less compelling.•Exposure to airborne molds is not recognized as a contributing factor in atopic dermatitis.•Exposure to airborne molds is not recognized as a cause of urticaria, angioedema, or anaphylaxis.•Patients with suspected mold allergy should be evaluated by means of an accepted method of skin or blood testing for IgE antibodies to appropriate mold antigens as part of the clinical evaluation of potential allergies. Allergic bronchopulmonary aspergillosis (ABPA) is a well-recognized clinical entity affecting individuals with asthma or cystic fibrosis.21Greenberger P.A. Allergic bronchopulmonary aspergillosis.J Allergy Clin Immunol. 2002; 110: 685-692Abstract Full Text Full Text PDF PubMed Scopus (413) Google Scholar A variety of fungi in addition to Aspergillus fumigatus can produce a similar clinical picture. The critical element in ABPA is an underlying anatomic change in the lung and not a specific mold exposure because at-risk individuals will have ongoing exposures caused by the ubiquitous nature of the fungi involved. Exposure to A fumigatus can occur both from indoor and outdoor sources. Allergic fungal sinusitis is similar to ABPA in that it is a localized hypersensitivity condition resulting from fungal growth in an area of abnormal tissue drainage.22Luong A. Marple B.F. Allergic fungal rhinosinusitis.Curr Allergy Asthma Rep. 2004; 4: 465-470Crossref PubMed Scopus (20) Google Scholar Although originally attributed primarily to A fumigatus, other fungi, particularly mitosporic (formerly known as Deuteromycetes or imperfect fungi) fungi are more commonly implicated (eg, Curvularia and Bipolaris species). Almost uniformly there is allergic sensitization to multiple allergens, including the fungus implicated in the affected sinus. Criteria for this condition have been well delineated, and it is generally readily distinguishable from typical chronic sinusitis. Specific criteria for diagnosis include eosinophilic mucus demonstrating noninvasive fungi, type 1 hypersensitivity (history, positive skin test result, or positive in vitro test result to allergens), nasal polyposis, and characteristic radiographic findings. It has recently been proposed that most cases of chronic rhinosinusitis (CRS) are attributable to sensitivity to fungi. In particular, Alternaria species were suspected because most patients had these organisms recovered by means of culture from sinus surgery specimens. However, these organisms are frequently recovered from the nasal cavities of healthy individuals. Although some evidence for an immune response to these fungi in patients with CRS has been presented, clear-cut evidence for this as the cause of CRS is still lacking, and treatment with intranasal antifungal agents (eg, amphotericin) has not been conclusively demonstrated to be an effective treatment.23Bush R.K. Is topical antifungal therapy effective in the treatment of chronic rhinosinusitis?.J Allergy Clin Immunol. 2005; 115: 123-124Abstract Full Text Full Text PDF PubMed Scopus (3) Google Scholar Conclusions:•ABPA and allergic fungal sinusitis are manifestations of significant hypersensitivity to fungi, particularly Aspergillus species.•Data supporting the role of fungi in CRS are lacking at this time. HP, also referred to as extrinsic allergic alveolitis, is a disease that exists in acute, subacute, and chronic forms but with considerable overlap. It is an allergic disease in which the allergen is inhaled in the form of an organic dust of bacterial, fungal, vegetable, or avian origin. Both sensitization and the elicitation of the disease state generally require high-dose exposure, prolonged exposure, or both to the causative allergen. Many cases are, in fact, occupational because of this. There are reports of a similar, if not identical, disease from workers exposed to inhaled chemicals, especially isocyanates. A few instances of the disease have been attributed to systemically administered drugs. HP is rare, and most cases have been reported in certain occupations, such as farming, and in hobbyists, such as persons who raise pigeons. It is not a reportable disease, and therefore prevalence and incidence are difficult to estimate. The immunopathogenesis of the disease is believed to be cell-mediated (delayed) hypersensitivity. Allergen-specific precipitins are often present in serum and are important is establishing exposure. Precipitins might also play a role in the mechanism of the acute phase of the disease. HP results in acute episodes of noninfectious, immunologically mediated interstitial pneumonitis (ie, alveolitis), which might eventually produce restrictive irreversible lung disease. The diagnosis requires a clinical and environmental history, relevant physical examination findings, chest radiography or computed tomographic scanning, high-resolution computed tomographic scanning, pulmonary function testing, bronchoalveolar lavage, and transbronchial or open lung biopsy. Specific diagnosis of the responsible allergen is performed by testing for IgG antibody to the allergen extract, typically by testing for the presence of precipitins in the Ouchterlony double-diffusion assay. In some instances provocation inhalation challenge to the suspected allergen extract might be necessary to replicate pertinent clinical and laboratory responses. Finally, a favorable response to the elimination of the inhaled antigen, administration of prednisone, or both is confirmatory. Because a differential diagnosis covers a number of respiratory diseases, an accurate diagnosis of HP demands that the clinical diagnosis be ensured. Exposure to domestic specific indoor fungal spores is an extremely unlikely cause of HP, except in highly unusual circumstances, such as workplace exposure. Conclusions:•HP is an uncommon but important disease that can occur as a result of mold exposure, particularly in occupational settings with high levels of exposure. Superficial mold infections (eg, tinea cruris, onychomycosis, and thrush) are common in healthy individuals and result primarily from local changes in the cutaneous or mucosal barrier, resident microflora, or both.24Mandell G.L. Bennett J.E. Dolan R. Principles and practice of infectious diseases.6th ed. Churchill Livingstone, London2004Google Scholar, 25Feigin R.D. Cherry J.D. Demmler G.J. Kaplan S. Textbook of pediatric infectious diseases.5th ed. Saunders, Philadelphia2003Google Scholar These infections are not the result of environmental exposure, except occasionally as related to certain animal vectors. Indeed, molds of the Malassezia genus are resident on the vast majority of human subjects and only become evident as “tinea versicolor” during periods of more exuberant growth. A limited number of molds (eg, coccidiomycosis, histoplasmosis, and blastomycosis) are aggressive pathogens in otherwise healthy persons. Acquisition of these infections is generally related to specific outdoor activities-exposures. Individuals with recognized primary and secondary immunodeficiency disorders are at increased risk for infection with a wide range of opportunistic fungi, with the risk varying with the degree and nature of the specific immunodeficiency. Opportunistic fungal infections are typically associated with cellular rather than (isolated) humoral immunodeficiencies. Generally, host factors, rather than environmental exposure, are the critical factor in the development of opportunistic mold infection in immunocompromised individuals because exposure to potential fungal opportunistic pathogens (eg, Aspergillus species) is ubiquitous in normal outdoor and indoor environments. Accepted histologic and microbiologic methods should be used to make the diagnosis of fungal infection. Conclusions:•Common superficial fungal infections are determined by local changes in the skin barrier, resident microflora, or both.•A very limited number of aggressive fungal pathogens can be acquired through specific outdoor exposures.•Host factors, rather then environmental exposure, are the main determinant of opportunistic fungal infection. Ingestion of mycotoxins in large doses (generally on the order of a milligram or more per kilogram of body weight) from spoiled or contaminated foods can cause severe human illness.26Fung F. Clark R.F. Health effects of mycotoxins: a toxicological overview.Toxicol Clin Toxicol. 2004; 42: 217-234Crossref PubMed Scopus (193) Google Scholar Toxicity from ingested mycotoxins is primarily a concern in animal husbandry, although human outbreaks do occur occasionally when starvation forces subjects to eat severely contaminated food. Specific adverse effects from a given toxin generally occur in a narrower and better-defined dose range than for immunologic or allergic effects that might vary across much broader dose ranges. Some mycotoxins, such as ocratoxins and aflatoxins, are commonly found in food stuffs, including grain products and wines, and peanut products, respectively, such that there are governmental regulations as to the amounts of allowable aflatoxin in foods.27Monaci L. Palmisano F. Determination of ochratoxin A in foods: state-of-the-art and analytical challenges.Anal Bioanal Chem. 2004; 378: 96-103Crossref PubMed Scopus (155) Google Scholar, 28Title 21–Food and Drugs. College Park (Md): Center for Food Safety and Applied Nutrition; 2004. Available at: http://www.cfsan.fda.gov∼lrd/cfr110.html, http://www.cfsan.fda.gov/∼lrd/fdaact.html. Accessed December 20, 2005.Google Scholar Acute high-intensity occupational exposures to mixed bioaerosols have given rise to a clinical picture called “toxic dust syndrome.” The nature of the responsible agent or agents in that condition remains undefined, and the observed adverse effects reported have been transient. Such exposures are highly unlikely in nonoccupational settings. The term mold toxicity as used here refers to the direct injurious effects of mold-produced molecules, so-called mycotoxins, on cellular function. Toxicity should not be used to refer to changes related to innate immune responses (eg, nonspecific inflammation caused by mold particulates) or to adaptive immune responses (eg, induction of IgE or IgG antibodies). Mycotoxins are low-molecular-weight chemicals produced by molds that are secondary metabolites unnecessary for the primary growth and reproduction of the organisms. In-depth review of the toxicology of mycotoxins and their potential for adverse health effects can be found elsewhere.1Committee on Damp Indoor Spaces and Health Board of Health Promotion and Disease Prevention. Institute of Medicine of the National Academies. Damp indoor spaces and health. The National Academies Press, Washington (DC)2004Google Scholar, 2Committee on the Assessment of Asthma and Indoor Air Division of Health Promotion and Disease Prevention. Institute of Medicine. Clearing the air: asthma and indoor air exposure. The National Academy Press, Washington (DC)2002Google Scholar It is important to emphasize key principles of toxicology relevant to patient concerns about possible toxic effects from mold exposure. Only certain mold species produce specific mycotoxins under specific circumstances. Importantly, the mere presence of such a mold should not be taken as evidence that the mold was producing any mycotoxin. For a toxic effect to occur in a subject, (1) the toxin must be present, (2) there must be a route of exposure, and (3) the subject must receive a sufficient dose to have a toxic effect. In the nonoccupational setting the potential route of exposure is through inhalation. Mycotoxins are not volatile and, if found in the respirable air, are associated with mold spores or particulates. They are not cumulative toxins, having half-lives ranging from hours to days depending on the specific mycotoxin. Calculations for both acute and subacute exposures on the basis of the maximum amount of mycotoxins found per mold spore for various mycotoxins and the levels at which adverse health effects are observed make it highly improbable that home or office mycotoxin exposures would lead to a toxic adverse health effects.1Committee on Damp Indoor Spaces and Health Board of Health Promotion and Disease Prevention. Institute of Medicine of the National Academies. Damp indoor spaces and health. The National Academies Press, Washington (DC)2004Google Scholar, 29Robbins C.A. Swenson L.J. Hardin B.D. Risk from inhaled mycotoxins in indoor office and residential environments.Int J Toxicol. 2004; 23: 3-10PubMed Google Scholar Thus we agree with the American College of Occupational and Environmental Medicine evidence-based statement and the Institute of Medicine draft, which conclude that the evidence does not support the contention that mycotoxin-mediated disease (mycotoxicosis) occurs through inhalation in nonoccupational settings. Furthermore, the contention that the presence of mycotoxins would give rise to a whole panoply of nonspecific complaints is not consistent with what is known to occur; when a toxic dose is achieved (eg, through ingestion of spoiled foods), there is a specific pattern of illness seen for specific mycotoxins. Conclusions:•The occurrence of mold-related toxicity (mycotoxicosis) from exposure to inhaled mycotoxins in nonoccupational settings is not supported by the current data, and its occurrence is improbable. The Occupational Health and Safety Administration defines an irritant as a material causing “a reversible inflammatory effect on living tissue by chemical action at the site of contact.” Irritant effects are dose related, and the effects are transient, disappearing when the exposure has decreased or ceased. Molds produce a number of potentially irritating substances that can be divided into volatile organic compounds (VOCs) and particulates (eg, spores, hyphae fragments, and their components). The threshold level of irritant response depends on the intrinsic properties of the specific material involved, the level plus length of exposure, and the innate sensitivity of the exposed tissues (eg, the skin versus nasal mucosa). VOCs made by molds (MVOCs) are responsible for their musty odor. MVOCs include a wide range of alcohols, ketones, aldehydes, esters, carboxylic acids, lactones, terpenes, sulfur and nitrogen compounds, and aliphatic and aromatic hydrocarbons.30Pasanen A.-L. Korpi A. Kasanen J.-P. Pasanen P. Critical aspects on the significance of microbial volatile metabolites as indoor air pollutants.Environ Int. 1998; 24: 703-712Crossref Scopus (69) Google Scholar Although levels causing irritant effects have been established for many VOCs, MVOC levels measured in damp buildings are usually at a level so low (on the order of nanograms to micrograms per cubic meter) that exposure would not be expected to cause complaints of irritation in human subjects.31Pasanen A.-L. Lappalainen S. Pasanen P. Volatile organic metabolites associated with some toxic fungi and their mycotoxins.Analyst. 1996; 121: 1949-1953Crossref Scopus (81) Google Scholar Because there are other sources of VOCs indoors, measurement of indoor airborne concentrations of MVOCs is rarely done. Mold particles (spores, hyphal fragments, and their structural components) are not volatile. These structural mold compounds (particulates) have been suggested to cause inflammation through deposition on mucus membranes of their attached glucans and mannans. However, whether such effects occur clinically remains unproved. In fact, subjects exposed to airborne concentrations of between 215,000 and 1,460,000 mold spores/m3Horner W.E. Helbing A. Salvaggio J.E. Lehrer S.B. Fungal allergens.Clin Microbiol Rev. 1995; 8: 161-179Crossref PubMed Google Scholar at work showed no differences in respiratory symptoms at work versus while on vacation nor was there evidence of increased inflammatory markers in their nasal lavage fluids related to their mold exposure at work.32Roponen M. Seuir M. Nevalainen A. Hirvonen M.R. Fungal spores as such do not cause nasal inflammation in mold exposure.Inhal Toxicol. 2002; 14: 541-549Crossref PubMed Scopus (28) Google Scholar Thus mold particulates generally found indoors, even in damp buildings, are not likely to be irritating. It should be emphasized that irritant effects involve the mucus membranes of the eyes and upper and lower respiratory tracts and are transient, so that symptoms or signs persisting weeks after exposure and those accompanied by neurologic, cognitive, or systemic complaints (eg, chronic fatigue) should not be ascribed to irritant exposure. Conclusions:•The occurrence of mold-related irritant reactions from exposure to fungal irritants in nonoccupational settings are theoretically possible, although unlikely to occur in the general population given exposure and dose considerations.•Such irritant effects would produce transient symptoms-signs related to the mucus membranes of the eyes and upper and lower respiratory tracts but would not be expected to manifest in other organs or in a systemic fashion.•Further information about thresholds for irritant reactions in at-risk populations is needed to better define the role of molds, mold products, and other potential irritants in such individuals. The question has been raised as to whether mold or mycotoxin exposure can induce disorders of immune regulation. At this time, there is no credible evidence to suggest that environmental exposure to molds or their products leads to a state of clinically significant altered immunity expressed as either immunodeficiency or autoimmunity. The published literature in this regard is of particularly poor quality and should not be relied on as scientifically valid.33Gray M.R. Thrasher J.
Publication Year: 2006
Publication Date: 2006-02-01
Language: en
Type: review
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 396
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot